Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Allott

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Schizophrenia Research|September 2, 2022
Intelligence trajectories in individuals at ultra-high risk for psychosis: An 8-year longitudinal analysisNicholas Cheng, Ashleigh Lin, Stephen Bowden, et al.
Schizophrenia Research. Cognition|March 4, 2021
Cognitive ability and metabolic physical health in first-episode psychosisSarah Whitson, Brian O'Donoghue, Robert Hester, et al.
JAMA Psychiatry|June 23, 2021
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical TrialSidhant Chopra, Shona M Francey, Brian O'Donoghue, et al.
Translational Psychiatry|April 18, 2023
Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypyMarianne Oldehinkel, Jeggan Tiego, Kristina Sabaroedin, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 4, 2025
The neurophenomenology of basic self-disturbance in early psychosis: Association with clinical outcome in an ultra-high risk sampleVera A Barata, Suzie Lavoie, Łukasz Gawęda, et al.
Biological Psychiatry|July 28, 2024
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode PsychosisSidhant Chopra, Priscila T Levi, Alexander Holmes, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 5, 2023
Combining Clinical With Cognitive or Magnetic Resonance Imaging Data for Predicting Transition to Psychosis in Ultra High-Risk Patients: Data From the PACE 400 CohortSimon Hartmann, Micah Cearns, Christos Pantelis, et al.
Early Intervention in Psychiatry|October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
Translational Psychiatry|June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trialKelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Schizophrenia Research|September 2, 2022
Intelligence trajectories in individuals at ultra-high risk for psychosis: An 8-year longitudinal analysisNicholas Cheng, Ashleigh Lin, Stephen Bowden, et al.
Schizophrenia Research. Cognition|March 4, 2021
Cognitive ability and metabolic physical health in first-episode psychosisSarah Whitson, Brian O'Donoghue, Robert Hester, et al.
JAMA Psychiatry|June 23, 2021
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical TrialSidhant Chopra, Shona M Francey, Brian O'Donoghue, et al.
Translational Psychiatry|April 18, 2023
Gradients of striatal function in antipsychotic-free first-episode psychosis and schizotypyMarianne Oldehinkel, Jeggan Tiego, Kristina Sabaroedin, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 4, 2025
The neurophenomenology of basic self-disturbance in early psychosis: Association with clinical outcome in an ultra-high risk sampleVera A Barata, Suzie Lavoie, Łukasz Gawęda, et al.
Biological Psychiatry|July 28, 2024
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode PsychosisSidhant Chopra, Priscila T Levi, Alexander Holmes, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 5, 2023
Combining Clinical With Cognitive or Magnetic Resonance Imaging Data for Predicting Transition to Psychosis in Ultra High-Risk Patients: Data From the PACE 400 CohortSimon Hartmann, Micah Cearns, Christos Pantelis, et al.
Early Intervention in Psychiatry|October 5, 2022
Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)Brian O'Donoghue, Kelly Allott, Susy Harrigan, et al.
Translational Psychiatry|June 10, 2023
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trialKelly Allott, Hok Pan Yuen, Lara Baldwin, et al.
Brain : a Journal of Neurology|January 30, 2022
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuumKristina Sabaroedin, Adeel Razi, Sidhant Chopra, et al.
Pageof 14